Background
Methods
Study setting
Survey instrument
Measures
Respondent sociodemographic variables
Respondent drug-related behaviours
Egocentric network variables
IDU risk network variables
Diagnostic testing
Statistical analysis
Results
Correlation between HCV, HBV, and HIV
Univariate analyses
Variable name | HCV negative (n = 167) (%) | HCV positive (n = 198) (%) | OR (95% CI) | p value |
---|---|---|---|---|
Respondent variables
| ||||
Years of injection drug use (quartiles)
| ||||
0–6 | 81 (48.5) | 20 (10.1) | 1.0 | |
7–13 | 46 (27.5) | 51 (25.8) | 4.5 (2.4–8.4) | <0.001 |
14–21 | 19 (11.4) | 61 (30.8) | 13.0 (6.4–26.5) | <0.001 |
22–39 | 21 (12.6) | 66 (33.3) | 12.7 (6.4–25.5) | <0.001 |
Gender
| ||||
Male | 96 (57.5) | 113 (57.1) | 1.0 | |
Female | 71 (42.5) | 85 (42.9) | 1.0 (0.7–1.5) | 0.937 |
Education level
| ||||
< grade 12 | 116 (69.5) | 142 (71.7) | 1.0 | |
> grade 12 | 51 (30.5) | 56 (28.3) | 0.9 (0.6–1.4) | 0.637 |
Ethnicity
| ||||
Caucasian | 71 (42.5) | 57 (28.8) | 1.0 | |
Aboriginal | 96 (57.5) | 141 (71.2) | 1.8 (1.2–2.8) | 0.006 |
Moved to Winnipeg in past year
| ||||
No | 112 (67.1) | 153 (77.3) | 1.0 | |
Yes | 55 (32.9) | 45 (22.7) | 0.6 (0.4–1.0) | 0.030 |
Deals drugs
| ||||
No | 85 (50.9) | 107 (54.0) | 1.0 | |
Yes | 82 (49.1) | 91 (46.0) | 0.9 (0.6–1.3) | 0.549 |
Cocaine use
| ||||
No | 62 (37.1) | 69 (34.9) | 1.0 | |
Yes | 105 (62.9) | 129 (65.1) | 1.1 (0.7–1.7) | 0.651 |
Talwin/ritalin use
| ||||
No | 134 (80.2) | 113 (57.1) | 1.0 | |
Yes | 33 (19.8) | 85 (42.9) | 3.1 (1.9–4.9) | <0.001 |
Morphine use
| ||||
No | 110 (65.9) | 121 (61.1) | 1.0 | |
Yes | 57 (34.1) | 77 (38.9) | 1.2 (0.8–1.9) | 0.347 |
Heroin use
| ||||
No | 145 (86.8) | 184 (92.9) | 1.0 | |
Yes | 22 (13.2) | 14 (7.1) | 0.5 (0.2–1.0) | 0.052 |
Injects daily
| ||||
No | 20 (12.0) | 43 (21.7) | 1.0 | |
Yes | 147 (88.0) | 155 (78.3) | 0.5 (0.3–0.9) | 0.013 |
Injected at a hotel
| ||||
No | 109 (65.3) | 107 (54.0) | 1.0 | |
Yes | 58 (34.7) | 91 (46.0) | 1.6 (1.0–2.4) | 0.029 |
Injected at a shooting gallery
| ||||
No | 153 (91.6) | 156 (78.8) | 1.0 | |
Yes | 14 (8.4) | 42 (21.2) | 2.9 (1.5–5.6) | <0.001 |
Ever used someone else's syringe
| ||||
No | 90 (53.9) | 49 (24.8) | 1.0 | |
Yes | 77 (46.1) | 149 (75.3) | 3.6 (2.3–5.5) | <0.001 |
Injected someone else as a service
| ||||
No | 144 (86.2) | 125 (63.1) | 1.0 | |
Yes | 23 (13.8) | 73 (36.9) | 3.7 (2.2–6.2) | <0.001 |
Obtains syringes from friends
| ||||
No | 50 (29.9) | 73 (36.9) | 1.0 | |
Yes | 117 (70.1) | 125 (63.1) | 0.7 (0.5–1.1) | 0.162 |
Obtains syringes from questionable sources
| ||||
No | 135 (80.8) | 144 (72.7) | 1.0 | |
Yes | 32 (19.2) | 54 (27.3) | 1.6 (1.0–2.6) | 0.067 |
Opposite-sex regular partners
| ||||
No | 51 (30.5) | 65 (31.8) | 1.0 | |
Yes | 116 (69.5) | 163 (68.2) | 0.9 (0.6–1.4) | 0.640 |
Opposite-sex casual partners
| ||||
No | 101 (60.5) | 129 (65.2) | 1.0 | |
Yes | 66 (39.5) | 69 (34.9) | 0.8 (0.5–1.3) | 0.357 |
Opposite-sex client partners
| ||||
No | 151 (90.4) | 163 (82.3) | 1.0 | |
Yes | 16 (9.6) | 35 (17.7) | 2.0 (1.1–3.8) | 0.024 |
Regular same-sex partners
| ||||
No | 160 (95.8) | 195 (98.5) | 1.0 | |
Yes | 7 (4.2) | 3 (1.5) | 0.4 (0.1–1.4) | 0.116 |
Casual same-sex partners
| ||||
No | 160 (95.8) | 191 (96.5) | 1.0 | |
Yes | 7 (4.2) | 7 (3.5) | 0.8 (0.3–2.4) | 0.745 |
Client same-sex partners
| ||||
No | 163 (97.6) | 194 (98.0) | 1.0 | |
Yes | 4 (2.4) | 4 (2.0) | 0.8 (0.2–3.4) | 0.808 |
Egocentric network variables (maximum number of network members = 20)
| ||||
Total number of IDU in network
| ||||
Median (IQR) | 3 (1,5) | 3 (1,5) | 1.0 (1.0–1.1) | 0.194 |
Total number of IDU family members in network
| ||||
Median (IQR) | 0 (0,0) | 0 (0,1) | 1.29 (1.1–1.6) | 0.10 |
Spouse IDU in network
| ||||
No | 109 (65.3) | 127 (64.1) | 1.0 | |
Yes | 58 (34.7) | 71 (35.9) | 1.1 (0.7–1.6) | 0.822 |
IDU risk network variables (maximum number of IDU = 5)
| ||||
Number of IDU respondent sees daily
| ||||
None | 54 (32.3) | 66 (33.3) | 1.0 | |
1 | 55 (32.9) | 68 (34.3) | 1.0 (0.6–1.7) | 0.964 |
2 | 32 (19.2) | 30 (15.2) | 0.8 (0.4–1.4) | 0.398 |
3–5 | 26 (15.6) | 34 (17.2) | 1.1 (0.6–2.0) | 0.832 |
Number of IDU in network who inject daily
| ||||
None | 104 (62.3) | 105 (53.0) | 1.0 | |
1 | 32 (19.2) | 36 (18.2) | 1.1 (0.6–1.9) | 0.699 |
2 | 19 (11.4) | 31 (15.7) | 1.6 (0.9–3.0) | 0.137 |
3–5 | 12 (7.2) | 26 (13.1) | 2.1 (1.0–4.5) | 0.042 |
Number of IDU in network who have been IDU for >5 years
| ||||
0 | 101 (60.5) | 74 (37.4) | 1.0 | |
1 | 28 (16.8) | 40 (20.2) | 1.9 (1.1–3.4) | 0.021 |
2 | 18 (10.8) | 39 (19.7) | 3.0 (1.6–5.6) | 0.001 |
3–5 | 20 (12.0) | 45 (22.7) | 3.1 (1.7–5.6) | <0.001 |
Number of IDU in network who have injected at a hotel
| ||||
0 | 117 (70.1) | 112 (56.6) | 1.0 | |
1 | 29 (17.4) | 39 (19.7) | 1.4 (0.8–2.4) | 0.222 |
2–5 | 21 (12.6) | 47 (23.7) | 2.3 (1.3–4.2) | 0.004 |
Number of IDU in network who have injected at a shooting gallery
| ||||
0 | 134 (80.2) | 143 (72.2) | 1.0 | |
1 | 18 (10.8) | 27 (13.6) | 1.4 (0.7–2.7) | 0.298 |
2–5 | 15 (9.0) | 28 (14.1) | 1.7 (0.9–3.4) | 0.102 |
Number of IDU in network with whom respondent has pooled money
| ||||
0 | 51 (30.5) | 56 (28.3) | 1.0 | |
1 | 42 (25.2) | 54 (27.3) | 1.2 (0.7–2.0) | 0.576 |
2–3 | 43 (25.8) | 55 (27.8) | 1.2 (0.7–2.0) | 0.587 |
4–5 | 31 (18.6) | 33 (16.7) | 1.0 (0.5–1.8) | 0.922 |
Number of IDU in network who have used a syringe before the respondent used it
| ||||
0 | 133 (79.6) | 146 (73.7) | 1.0 | |
1 | 27 (16.2) | 32 (16.2) | 1.1 (0.6–1.9) | 0.790 |
2–5 | 7 (4.2) | 20 (10.1) | 2.6 (1.1–6.4) | 0.036 |
Number of IDU in network who have used other drug paraphernalia before respondent has used it. | ||||
0 | 105 (62.9) | 119 (60.1) | 1.0 | |
1 | 29 (17.4) | 31 (16.7) | 0.9 (0.5–1.7) | 0.841 |
2–5 | 33 (19.8) | 48 (24.2) | 1.3 (0.8–2.1) | 0.342 |
Number of IDU in network who have initiated respondent to injection drug use
| ||||
0 | 110 (65.9) | 157 (79.3) | 1.0 | |
1 | 48 (28.8) | 35 (17.7) | 0.5 (0.3–0.8) | 0.008 |
2–5 | 9 (5.4) | 6 (3.0) | 0.5 (0.2–1.4) | 0.160 |
Number of IDU in network who have shown respondent how to inject drugs
| ||||
0 | 104 (62.3) | 147 (74.2) | 1.0 | |
1 | 43 (25.8) | 39 (19.7) | 0.6 (0.4–1.1) | 0.083 |
2–5 | 20 (12.0) | 12 (6.1) | 0.4 (0.2–0.9) | 0.027 |
Number of IDU in network who have injected respondent with drugs
| ||||
0 | 89 (53.3) | 88 (44.4) | 1.0 | |
1 | 44 (26.4) | 54 (27.3) | 1.2 (0.8–2.0) | 0.392 |
2–5 | 34 (20.4) | 56 (28.3) | 1.7 (1.0–2.8) | 0.054 |
Number of IDU in network who have used talwin/ritalin
| ||||
0 | 139 (83.2) | 119 (60.1) | 1.0 | |
1–3 | 17 (10.1) | 42 (21.1) | 2.9 (1.6–5.3) | <0.001 |
4–5 | 11 (6.6) | 37 (18.7) | 3.9 (1.9–8.0) | <0.001 |
Number of IDU in network who have used cocaine
| ||||
0 | 113 (67.7) | 120 (60.6) | 1.0 | |
1 | 23 (13.8) | 36 (18.2) | 1.5 (0.8–2.6) | 0.192 |
2–3 | 17 (10.2) | 30 (15.2) | 1.7 (0.9–3.2) | 0.125 |
4–5 | 14 (8.4) | 12 (6.1) | 0.8 (0.4–1.8) | 0.605 |
Number of IDU in network who have used morphine
| ||||
0 | 129 (77.3) | 149 (75.3) | 1.0 | |
1 | 22 (13.2) | 31 (15.7) | 1.2 (0.7–2.2) | 0.513 |
2–5 | 16 (9.6) | 18 (9.1) | 1.0 (0.5–2.0) | 0.942 |
Variable name | HBV negative (n = 253) (%) | HBV positive (n = 111) (%) | OR (95% CI) | p value |
---|---|---|---|---|
Respondent variables
| ||||
Years of injection drug use (quartiles)
| ||||
0–6 | 97 (38.3) | 5 (4.5) | 1.0 | |
7–13 | 74 (29.3) | 23 (20.7) | 6.0 (2.2–16.6) | <0.001 |
14–21 | 42 (16.6) | 36 (32.4) | 16.6 (6.1–45.3) | <0.001 |
22–39 | 40 (15.8) | 47 (42.3) | 22.8 (8.4–61.5) | <0.001 |
Gender
| ||||
Male | 150 (59.3) | 60 (54.0) | 1.0 | |
Female | 103 (40.7) | 51 (46.0) | 1.2 (0.8–1.9) | 0.353 |
Education level
| ||||
< grade 12 | 178 (70.4) | 79 (71.2) | 1.0 | |
> grade 12 | 75 (29.6) | 32 (28.8) | 1.0 (0.6–1.3) | 0.485 |
Ethnicity
| ||||
Caucasian | 99 (39.1) | 29 (26.1) | 1.0 | |
Aboriginal | 154 (60.9) | 82 (73.9) | 1.8 (1.1–3.0) | 0.015 |
Mobility
| ||||
In Winnipeg > 1 year | 168 (66.4) | 97 (87.4) | 1.0 | |
Moved to Winnipeg in past year | 85 (33.6) | 14 (12.6) | 0.3 (0.2–0.5) | <0.001 |
Deals drugs
| ||||
No | 129 (51.0) | 61 (55.0) | 1.0 | |
Yes | 124 (49.01 | 50 (45.1) | 0.9 (0.5–1.3) | 0.485 |
Cocaine use
| ||||
No | 85 (33.6) | 44 (39.6) | 1.0 | |
Yes | 168 (66.4) | 67 (60.4) | 0.8 (0.5–1.2) | 0.27 |
Talwin/ritalin use
| ||||
No | 190 (75.1) | 55 (49.6) | 1.0 | |
Yes | 63 (24.9) | 56 (50.5) | 3.1 (1.9–4.9) | <0.001 |
Morphine use
| ||||
No | 165 (64.8) | 68 (61.3) | 1.0 | |
Yes | 89 (35.2) | 43 (38.7) | 1.2 (0.7–1.8) | 0.516 |
Heroin use
| ||||
No | 222 (87.8) | 106 (95.5) | 1.0 | |
Yes | 31 (12.3) | 5 (4.5) | 0.3 (0.1–0.9) | 0.015 |
Injects daily
| ||||
No | 34 (13.4) | 26 (23.4) | 1.0 | |
Yes | 219 (86.6) | 85 (76.6) | 0.5 (0.3–0.9) | 0.021 |
Injected at a hotel
| ||||
No | 160 (63.2) | 53 (47.8) | 1.0 | |
Yes | 93 (36.8) | 58 (52.2) | 1.9 (1.2–3.0) | 0.006 |
injected at a shooting gallery
| ||||
No | 224 (88.5) | 85 (62.2) | 1.0 | |
Yes | 29 (11.5) | 26 (23.4) | 2.4 (1.3–4.2) | 0.004 |
Ever used someone else's syringe
| ||||
No | 114 (45.1) | 25 (22.5) | 1.0 | |
Yes | 139 (54.9) | 86 (77.5) | 2.8 (1.7–4.7) | <0.001 |
Injected someone else as a service
| ||||
No | 204 (80.6) | 66 (59.5) | 1.0 | |
Yes | 49 (19.4) | 45 (40.6) | 2.8 (1.7–4.6) | <0.001 |
Obtains syringes from friends
| ||||
No | 81 (32.0) | 41 (16.9) | 1.0 | |
Yes | 172 (68.0) | 70 (63.1) | 0.8 (0.5–1.3) | 0.362 |
Obtains syringes from questionable sources
| ||||
No | 197 (77.9) | 81 (73.0) | 1.0 | |
Yes | 56 (22.1) | 30 (27.0) | 1.3 (0.8–2.2) | 0.316 |
Opposite-sex regular partners
| ||||
No | 81 (32.0) | 36 (32.4) | 1.0 | |
Yes | 172 (68.0) | 75 (67.6) | 1.0 (0.6–1.6) | 0.938 |
Opposite-sex casual partners
| ||||
No | 149 (58.9) | 80 (72.1) | 1.0 | |
Yes | 104 (41.1) | 31 (27.9) | 0.6 (0.3–0.9) | 0.015 |
Opposite-sex client partners
| ||||
No | 223 (88.1) | 90 (81.1) | 1.0 | |
Yes | 30 (11.9) | 21 (18.9) | 1.7 (0.9–3.2) | 0.081 |
Regular same-sex partners
| ||||
No | 245 (96.8) | 109 (98.2) | 1.0 | |
Yes | 8 (3.2) | 2 (1.8) | 0.6 (0.1–2.7) | 0.448 |
Casual same-sex partners
| ||||
No | 240 (94.9) | 109 (98.2) | 1.0 | |
Yes | 13 (5.1) | 2 (1.8) | 0.3 (0.1–1.5) | 0.113 |
Client same-sex partners
| ||||
No | 247 (97.6) | 109 (98.2) | 1.0 | |
Yes | 6 (2.4) | 2 (1.8) | 0.8 (0.2–3.8) | 0.728 |
Egocentric network variables (maximum number of network members = 20)
| ||||
Total number of IDU in network
| ||||
Median (IQR) | 3 (1,4) | 3 (2,5) | 1.1 (1.0–1.2) | 0.001 |
Total number of IDU family members in network
| ||||
Median (IQR) | 0 (0,1) | 0 (0,1) | 1.3 (1.0–1.5) | 0.019 |
Spouse IDU in network
| ||||
No | 169 (66.8) | 69 (62.2) | 1.0 | |
Yes | 84 (33.2) | 42 (37.8) | 1.2 (0.8–1.9) | 0.394 |
IDU risk network variables (maximum number of IDU = 5)
| ||||
Number of IDU respondent sees daily
| ||||
None | 83 (32.8) | 38 (34.2) | 1.0 | |
1 | 84 (33.2) | 38 (34.2) | 1.0 (0.6–1.7) | 0.965 |
2 | 48 (19.0) | 13 (11.7) | 0.6 (0.3–1.2) | 0.155 |
3–5 | 38 (15.0) | 22 (19.8) | 1.3 (0.7–2.4) | 0.479 |
Number of IDU in network who inject daily
| ||||
None | 160 (63.2) | 50 (45.1) | 1.0 | |
1 | 42 (16.6) | 25 (22.5) | 1.9 (1.1–3.4) | 0.032 |
2 | 31 (12.3) | 17 (15.3) | 1.8 (0.9–3.4) | 0.101 |
3–5 | 20 (7.9) | 19 (17.1) | 3.0 (1.5–6.1) | 0.002 |
Number of IDU in network who have been IDU for >5 years
| ||||
0 | 142 (56.1) | 34 (30.6) | 1.0 | |
1 | 50 (19.8) | 18 (16.2) | 1.5 (0.8–2.9) | 0.223 |
2 | 32 (12.7) | 24 (21.6) | 3.1 (1.6–6.0) | 0.001 |
3–5 | 29 (11.5) | 35 (31.5) | 5.0 (2.7–9.4) | <0.001 |
Number of IDU in network who have injected at a hotel
| ||||
0 | 175 (69.2) | 54 (48.7) | 1.0 | |
1 | 48 (19.0) | 20 (18.0) | 1.4 (0.7–2.5) | 0.330 |
2–5 | 30 (11.9) | 37 (33.3) | 4.0 (2.3–7.1) | <0.001 |
Number of IDU in network who have injected at a shooting gallery
| ||||
0 | 204 (80.6) | 74 (66.7) | 1.0 | |
1 | 30 (11.9) | 15 (13.5) | 1.4 (0.7–2.7) | 0.351 |
2–5 | 19 (7.5) | 22 (19.8) | 3.2 (1.6–6.2) | 0.001 |
Number of IDU in network with whom respondent has pooled money
| ||||
0 | 84 (33.2) | 23 (20.7) | 1.0 | |
1 | 62 (24.5) | 33 (29.7) | 1.9 (1.0–3.6) | 0.037 |
2–3 | 64 (25.3) | 34 (30.6) | 1.9 (1.0–3.6) | 0.036 |
4–5 | 43 (17.0) | 21 (18.9) | 1.8 (0.9–3.6) | 0.103 |
Number of IDU in network who have used a syringe before the respondent used it
| ||||
0 | 191 (75.5) | 87 (78.4) | 1.0 | |
1 | 47 (18.6) | 12 (10.8) | 0.6 (0.3–1.1) | 0.097 |
2–5 | 15 (5.9) | 12 (10.8) | 1.8 (0.8–3.9) | 0.168 |
Number of IDU in network who have used other drug paraphernalia before respondent has used it. | ||||
0 | 155 (61.3) | 67 (60.4) | 1.0 | |
1 | 46 (18.2) | 13 (11.8) | 0.7 (0.3–1.3) | 0.220 |
2–5 | 52 (20.6) | 31 (27.9) | 1.4 (0.8–2.3) | 0.234 |
Number of IDU in network who have initiated respondent to injection drug use
| ||||
0 | 177 (70.0) | 88 (79.2) | 1.0 | |
1 | 63 (24.9) | 21 (18.9) | 0.7 (0.4–1.2) | 0.159 |
2–5 | 13 (5.1) | 2 (1.8) | 0.3 (0.1–1.4) | 0.128 |
Number of IDU in network who have shown respondent how to inject drugs
| ||||
0 | 172 (68.0) | 79 (71.2) | 1.0 | |
1 | 58 (22.9) | 23 (20.7) | 0.9 (0.5–1.5) | 0.602 |
2–5 | 23 (9.1) | 9 (8.1) | 0.8 (0.4–1.9) | 0.700 |
Number of IDU in network who have injected respondent with drugs
| ||||
0 | 133 (52.6) | 43 (38.7) | 1.0 | |
1 | 65 (25.7) | 33 (29.7) | 1.6 (0.9–2.7) | 0.103 |
2–5 | 55 (21.7) | 35 (31.5) | 2.0 (1.1–3.4) | 0.015 |
Number of IDU in network who have used talwin/ritalin
| ||||
0 | 197 (77.9 | 59 (53.2) | 1.0 | |
1–3 | 31 (12.3) | 29 (26.1) | 3.1 (1.7–5.6) | <0.001 |
4–5 | 25 (9.9) | 48 (13.2) | 3.1 (1.6–5.8) | 0.001 |
Number of IDU in network who have used cocaine
| ||||
0 | 168 (66.4) | 64 (57.7) | 1.0 | |
1 | 39 (15.4) | 20 (18.0) | 1.3 (0.7–2.5) | 0.340 |
2–3 | 26 (10.3) | 21 (18.9) | 2.1 (1.1–4.0) | 0.022 |
4–5 | 20 (7.9) | 26 (7.1) | 0.8 (0.3–2.0) | 0.625 |
Number of IDU in network who have used morphine
| ||||
0 | 198 (78.3) | 80 (72.1) | 1.0 | |
1 | 34 (13.4) | 18 (16.2) | 1.3 (0.7–2.5) | 0.399 |
2–5 | 21 (8.3) | 13 (11.7) | 1.5 (0.7–3.2) | 0.258 |
Variable name | HIV negative (n = 334) (%) | HIV positive (n = 26) (%) | OR (95% CI) | p value |
---|---|---|---|---|
Respondent variables
| ||||
Years of injection drug use (quartiles)
| ||||
0–6 | 100 (29.9) | 2 (7.7) | 1.0 | |
7–13 | 83 (24.9) | 11 (42.3) | 6.6 (1.4–30.7) | 0.016 |
14–21 | 71 (21.3) | 7 (26.9) | 4.9 (0.9–24.4) | 0.051 |
22–39 | 80 (24.0) | 6 (23.1) | 3.75 (0.7–19.0) | 0.111 |
Gender
| ||||
Male | 193 (57.8) | 13 (50.0) | 1.0 | |
Female | 141 (42.2) | 13 (50.0) | 1.4 (0.6–3.0) | 0.442 |
Education level
| ||||
< grade 12 | 234 (70.1) | 19 (73.1) | 1.0 | |
> grade 12 | 100 (29.9) | 7 (26.9) | 0.9 (0.4–2.1) | 0.744 |
Ethnicity
| ||||
Caucasian | 125 (37.4) | 3 (11.5) | 1.0 | |
Aboriginal | 209 (62.6) | 23 (88.5) | 4.6 (1.4–15.6) | 0.004 |
Mobility
| ||||
In Winnipeg > 1 year | 244 (73.1) | 18 (69.2) | 1.0 | |
Moved to Winnipeg in past year | 90 (27.0) | 8 (30.8) | 1.2 (0.5–2.9) | 0.677 |
Deals drugs
| ||||
No | 175 (52.4) | 15 (57.7) | 1.0 | |
Yes | 159 (47.6) | 11 (42.3) | 0.8 (0.4–1.8) | 0.601 |
Cocaine use
| ||||
No | 122 (36.5) | 6 (23.1) | 1.0 | |
Yes | 212 (63.5) | 20 (76.9) | 1.9 (0.7–4.9) | 0.154 |
Talwin/ritalin use
| ||||
No | 228 (68.3) | 16 (61.5) | 1.0 | |
Yes | 106 (31.7) | 10 (38.5) | 1.3 (0.6–3.1) | 0.486 |
Morphine use
| ||||
No | 209 (62.6) | 21 (80.8) | 1.0 | |
Yes | 125 (37.4) | 5 (19.2) | 0.4 (0.1–1.1) | 0.051 |
Heroin use
| ||||
No | 299 (89.5) | 26 (100) | ||
Yes | 35 (10.5) | 0 (0.00) | Not defined | |
Injects daily
| ||||
No | 52 (15.6) | 5 (19.2) | 1.0 | |
Yes | 282 (84.4) | 21 (80.8) | 0.8 (0.3–2.1) | 0.631 |
Injected at a hotel
| ||||
No | 198 (59.3) | 16 (61.5) | 1.0 | |
Yes | 136 (40.7) | 10 (38.5) | 0.9 (0.4–2.1) | 0.821 |
injected at a shooting gallery
| ||||
No | 287 (85.9) | 17 (65.4) | 1.0 | |
Yes | 47 (14.1) | 9 (34.6) | 3.2 (1.4–7.7) | 0.012 |
Ever used someone else's syringe
| ||||
No | 136 (40.7) | 2 (7.7) | 1.0 | |
Yes | 198 (59.3) | 24 (92.3) | 8.2 (1.9–35.5) | <0.001 |
Injected someone else as a service
| ||||
No | 256 (76.7) | 13 (50.0) | 1.0 | |
Yes | 78 (23.3) | 13 (50.0) | 3.3 (1.5–7.4) | 0.005 |
Obtains syringes from friends
| ||||
No | 106 (31.7) | 13 (50.0) | 1.0 | |
Yes | 228 (68.3) | 13 (50.0) | 0.5 (0.2–1.0) | 0.063 |
Obtains syringes from questionable sources
| ||||
No | 257 (77.0) | 19 (73.1) | 1.0 | |
Yes | 77 (23.1) | 7 (26.9) | 1.2 (0.5–3.0) | 0.658 |
Opposite-sex regular partners
| ||||
No | 105 (31.4) | 8 (30.8) | 1.0 | |
Yes | 229 (68.6) | 18 (69.2) | 1.0 (0.4–2.4) | 0.944 |
Opposite-sex casual partners
| ||||
No | 208 (62.3) | 18 (69.2) | 1.0 | |
Yes | 126 (37.7) | 8 (30.8) | 0.7 (0.3–1.7) | 0.474 |
Opposite-sex client partners
| ||||
No | 290 (86.8) | 19 (73.1) | 1.0 | |
Yes | 44 (37.7) | 7 (26.9) | 2.4 (1.0–6.1) | 0.076 |
Regular same-sex partners
| ||||
No | 326 (97.6) | 24 (92.3) | 1.0 | |
Yes | 8 (2.4) | 2 (7.7) | 3.4 (0.7–16.9) | 0.183 |
Casual same-sex partners
| ||||
No | 320 (95.8) | 25 (96.2) | 1.0 | |
Yes | 14 (4.2) | 1 (3.9) | 0.9 (0.1–7.2) | 0.932 |
Client same-sex partners
| ||||
No | 329 (98.5) | 23 (88.5) | 1.0 | |
Yes | 5 (1.5) | 3 (11.5) | 8.6 (1.9–38.2) | 0.013 |
Egocentric network variables (maximum number of network members = 20)
| ||||
Total number of IDU in network
| ||||
Median (IQR) | 3 (2,5) | 2 (0,5) | 0.9 (0.8–1.1) | 0.241 |
Total number of IDU family members in network
| ||||
Median (IQR) | 0 (0,1) | 0 (0,2) | 1.2 (0.9–1.6) | 0.260 |
Spouse IDU in network
| ||||
No | 215 (64.4)) | 17 (65.4) | 1.0 | |
Yes | 119 (35.6) | 9 (34.6) | 1.0 (0.4–2.2) | 0.917 |
IDU risk network variables (maximum number of IDU = 5)
| ||||
Number of IDU respondent sees daily
| ||||
None | 107 (32.0) | 12 (46.2) | 1.0 | |
1 | 112 (33.5) | 6 (23.1) | 0.5 (0.2–1.3) | 0.154 |
2 | 58 (17.4) | 5 (19.2) | 0.8 (0.3–2.3) | 0.637 |
3–5 | 57 (17.1) | 3 (11.5) | 0.5 (0.1–1.7) | 0.256 |
Number of IDU in network who inject daily
| ||||
None | 191 (57.2) | 17 (65.4) | 1.0 | |
1 | 63 (18.9) | 2 (7.7) | 0.4 (0.1–1.6) | 0.176 |
2 | 45 (13.5) | 4 (15.4) | 1.0 (0.3–3.1) | 0.998 |
3–5 | 35 (10.5) | 3 (11.5) | 1.0 (0.3–3.5) | 0.954 |
Number of IDU in network who have been IDU for >5 years
| ||||
0 | 159 (47.6) | 14 (53.9) | 1.0 | |
1 | 65 (19.5) | 3 (11.5) | 0.5 (0.1–1.9) | 0.323 |
2 | 52 (15.6) | 4 (15.4) | 0.9 (0.3–2.8) | 0.819 |
3–5 | 58 (17.4) | 5 (19.2) | 1.0 (0.3–2.8) | 0.969 |
Number of IDU in network who have injected at a hotel
| ||||
0 | 207 (62.0) | 20 (76.9) | 1.0 | |
1 | 64 (19.2) | 2 (7.7) | 0.3 (0.1–1.4) | 0.135 |
2–5 | 63 (18.9) | 4 (15.4) | 0.7 (0.2–2.0) | 0.458 |
Number of IDU in network who have injected at a shooting gallery
| ||||
0 | 254 (76.1) | 20 (76.9) | 1.0 | |
1 | 43 (12.9) | 2 (7.7) | 0.6 (0.1–2.6) | 0.488 |
2–5 | 37 (11.1) | 4 (15.4) | 1.4 (0.4–4.2) | 0.582 |
Number of IDU in network with whom respondent has pooled money
| ||||
0 | 94 (28.1) | 12 (46.2) | 1.0 | |
1 | 91 (27.3) | 4 (15.4) | 0.3 (0.1–1.1) | 0.074 |
2–3 | 90 (27.0) | 6 (23.1) | 0.5 (0.2–1.5) | 0.213 |
4–5 | 59 (17.7) | 4 (15.4) | 0.5 (0.2–1.7) | 0.292 |
Number of IDU in network who have used a syringe before the respondent used it
| ||||
0 | 255 (76.4) | 20 (76.9) | 1.0 | |
1 | 56 (16.8) | 4 (15.4) | 0.9 (0.3–2.8) | 0.869 |
2–5 | 23 (6.9) | 2 (7.7) | 1.1 (0.2–5.0) | 0.894 |
Number of IDU in network who have used other drug paraphernalia before respondent has used it. | ||||
0 | 201 (60.2) | 17 (65.4) | 1.0 | |
1 | 59 (17.7) | 3 (11.5) | 0.6 (0.2–2.1) | 0.429 |
2–5 | 74 (22.2) | 6 (23.1) | 1.0 (0.4–2.5) | 0.932 |
Number of IDU in network who have initiated respondent to injection drug use
| ||||
0 | 242 (72.5) | 21 (80.8) | 1.0 | |
1 | 77 (23.1) | 5 (19.2) | 0.7 (0.3–2.1) | 0.563 |
2–5 | 15 (4.5) | 0 (0.0) | Not defined | |
Number of IDU in network who have shown respondent how to inject drugs
| ||||
0 | 229 (68.6) | 19 (73.1) | 1.0 | |
1 | 75 (22.5) | 6 (23.1) | 1.0 (0.4–2.5) | 0.940 |
2–5 | 30 (9.0) | 1 (3.9) | 0.4 (0.1–3.1) | 0.382 |
Number of IDU in network who have injected respondent with drugs
| ||||
0 | 161 (48.2) | 12 (46.2) | 1.0 | |
1 | 95 (28.4) | 5 (19.2) | 0.7 (0.2–2.1) | 0.525 |
2–5 | 78 (23.4) | 9 (34.6) | 1.5 (0.6–3.8) | 0.344 |
Number of IDU in network who have used talwin/ritalin
| ||||
0 | 239 (71.6) | 17 (65.4) | 1.0 | |
1–3 | 54 (16.2) | 4 (15.4) | 1.0 (0.3–3.2) | 0.944 |
4–5 | 41 (12.3) | 5 (19.2) | 1.7 (0.6–4.9) | 0.315 |
Number of IDU in network who have used cocaine
| ||||
0 | 210 (62.9) | 18 (69.2) | 1.0 | |
1 | 55 (16.5) | 3 (11.5) | 0.6 (0.2–2.2) | 0.481 |
2–3 | 44 (13.2) | 4 (15.4) | 1.1 (0.3–3.3) | 0.919 |
4–5 | 25 (7.5) | 1 (3.9) | 0.5 (0.1–3.6) | 0.467 |
Number of IDU in network who have used morphine
| ||||
0 | 255 (76.4) | 21 (80.8) | 1.0 | |
1 | 46 (13.8) | 4 (15.4) | 1.1 (0.3–3.2) | 0.924 |
2–5 | 33 (9.9) | 1 (3.9) | 0.4 (0.0–2.8) | 0.336 |
Multivariate analyses
Reported injection with used syringe | |||
---|---|---|---|
A) | |||
Yes | No | ||
Number of talwin/ritalin users in IDU risk network
| 0 | 7.9 (3.7–16.8) 95 HCV +/58 HCV - (62%) | 1.00 24 HCV +/81 HCV - (22.9%) |
1–3 | 0.6 (0.3–42.4) 26 HCV +/10 HCV - (72%) | 1.00 16 HCV +/7 HCV - (69.6%) | |
4–5 | 1.0 (0.2–156.8) 28 HCV +/9 HCV - (76%) | 1.00 9 HCV +/2 HCV - (81.8%) | |
B) | |||
Reported injection with used syringe
| |||
Yes | No | ||
Number of IDU who have shown the respondent how to inject drugs
| 0 | 7.9 (3.7–16.8) 111 HCV +/41 HCV - (73.0%) | 1.00 36 HCV +/63 HCV - (36.4%) |
1 | 7.7 (0.3–37.1) 31 HCV +/23 HCV - (57.4%) | 1.00 8 HCV +/20 HCV - (28.6%) | |
2–5 | 0.4 (0.2–87.2) 7 HCV +/13 HCV - (33.3%) | 1.00 5 HCV +/7 HCV - (41.6%) |
Discussion
Conclusion
Variable name | OR (95% CI) | p value |
---|---|---|
Years of injection drug use Categories based on quartiles (Q1–Q4 below) | ||
Q2 vs. Q1 | 3.1 (1.5–6.2) | 0.002 |
Q3 vs. Q1 | 10.8 (4.8–24.5) | <0.001 |
Q4 vs. Q1 | 10.3 (4.7–22.6) | <0.001 |
injected at a shooting gallery
| ||
Yes vs. no | 4.3 (1.8–10.5) | <0.001 |
Ever used someone else's used syringe
| See table 5 | |
Number of IDU in network who use talwin/ritalin
| See table 5 | |
Number of IDU in network who have shown respondent how to inject drugs
| See table 5 |
Variable name | OR (95% CI) | p value |
---|---|---|
Years of injection drug use Categories based on quartiles (Q1–Q4 below) | ||
Q2 vs. Q1 | 4.7 (1.6–13.9) | 0.005 |
Q3 vs. Q1 | 11.3 (3.8–33.2) | <0.001 |
Q4 vs. Q1 | 15.7 (5.3–46.5) | <0.001 |
Ever used someone else's used syringe
| ||
Yes vs. No | 2.2 (1.2–4.0) | 0.005 |
injected at a shooting gallery
| ||
Yes vs. no | 2.9 (1.3–6.3) | 0.020 |
Opposite-sex casual sex partners
| ||
Yes vs No | 0.5 (0.3–0.9) | 0.020 |
Mobility (Moved to Winnipeg in past year)
| ||
Yes vs. no | 0.3 (0.2–0.7) | 0.004 |
Number of IDU in network who use talwin/ritalin
| ||
1–3 vs. none | 2.9 (1.4–5.9) | <0.005 |
4–5 vs none | 3.2 (1.4–7.2) | <0.009 |
Number of IDU in network who have intiated respondent to injection drug use
| ||
1 vs. none | 0.6 (0.3–1.4) | 0.248 |
2–5 vs. none | 0.1 (0.02–0.8) | 0.023 |
Number of IDU in risk network who have injected at a hotel
| ||
1 vs. none | 1.3 (0.6–2.6) | 0.490 |
2–5 vs. none | 2.8 (1.3–5.9) | 0.006 |
Variable name | OR (95% CI) | p value |
---|---|---|
Ethnicity | ||
Aboriginal vs. caucasian | 4.4 (1.2–15.6) | 0.022 |
Ever used someone else's used syringe
| ||
Yes vs. No | 8.7 (2.0–38.5) | 0.004 |
injected at a shooting gallery
| ||
Yes vs. no | 3.0 (1.2–7.5) | 0.018 |
Same-sex client sex partners
| ||
Yes vs No | 6.9 (1.5–32.4) | 0.014 |